Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of UnitedHealth Group due to allegations of materially misleading business information [1] Group 1: Investigation and Legal Action - Shareholders who purchased UnitedHealth securities may be entitled to compensation through a class action without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 2: Stock Performance and Earnings Report - UnitedHealth's stock fell 22.3% on April 17, 2025, after earnings fell short of Wall Street's expectations, primarily due to issues in its Medicare business [3] - The company substantially downgraded its projected results for 2025, which contributed to the stock decline [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]

Where do we start when the biggest Dow Industrials component, UnitedHealth Group Incorporated (NYSE: UNH ), drops to number 2 (behind The Goldman Sachs Group, Inc. ( GS )), thanks to losing 23% of its total market capitalization. In aI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden YARP Portfolio, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I've been charti ...

MILWAUKEE, April 24, 2025 /PRNewswire/ -- Ademi & Fruchter LLP is investigating possible securities fraud claims against UnitedHealth (NYSE: UNH). The investigation results from inaccurate statements UnitedHealth made regarding its business operations and prospects.Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.The investigation focuses on UnitedHealth's recent revisions ...

NEW YORK, April 23, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of UnitedHealth Group Incorporated (NYSE: UNH) resulting from allegations that UnitedHealth may have issued materially misleading business information to the investing public.So What: If you purchased UnitedHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

Group 1: UnitedHealth Group - UnitedHealth Group experienced a significant stock price drop of over 22% following a weak first-quarter report, marking its worst single-session decline since August 1998 [1] - The company was previously the largest component in the Dow Jones Industrial Average, but this position has now been taken over by Goldman Sachs [1][2] Group 2: Market Overview - Major indices including the Dow, S&P 500, and Nasdaq Composite are currently in correction territory, defined as a decline of at least 10% from recent highs [2] - Despite the downturn, there are potentially better dividend stocks in the Dow, such as Visa, Chevron, and Procter & Gamble, that investors may consider [2] Group 3: Visa - Visa operates a payment processing model that generates fees from credit and debit card transactions, maintaining partnerships with financial institutions [3] - The company boasts an impressive operating margin of 66.2% and a profit margin of 54.3%, indicating strong profitability [4] - Visa's business model allows it to remain profitable even during economic slowdowns, with a current dividend yield of 0.7% due to a focus on stock buybacks [5] - Visa is considered a safe investment option, especially in a declining stock market [6] Group 4: Chevron - Chevron offers a dividend yield of 5%, making it the second-highest yielding component in the Dow, with a history of 38 consecutive years of payout increases [7] - The company has faced a sell-off in 2025 due to falling oil and natural gas prices, influenced by macroeconomic concerns [8] - Key investment factors for Chevron include its reliable dividend, strong balance sheet with low debt, and improvements in operational efficiency [9] - The stock has declined by 16% over the last month, presenting a potential buying opportunity for income-focused investors [10] Group 5: Procter & Gamble - Procter & Gamble has shown resilience during market downturns, as consumer staples tend to maintain steady demand [11] - The company has significant international exposure, which makes it vulnerable to tariffs and currency fluctuations, but it has historically managed to pass on costs to consumers [12] - Procter & Gamble is set to report its fiscal 2025 third-quarter earnings soon, with investors keen on management's insights regarding tariffs and trade issues [13] - With 69 consecutive years of dividend increases and a yield of 2.5%, Procter & Gamble is viewed as a safe investment, although its valuation is considered high at 27.2 times earnings [14]

There's a new commodity in the financial markets today, and that's any stock (or business, for that matter) that carries a certain level of immunity to the recent trade tariffs rolled out by President Trump. With the level of uncertainty and volatility spreading across the S&P 500 index and other global markets, these stocks will be the most oversubscribed once more participants realize that safety and immunity will trade at a premium. In today's list, investors will have access to some of these stocks that ...

On this news, UnitedHealth's stock fell 22.3% on April 17, 2025 WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions a ...

UnitedHealth Group Today UNH UnitedHealth Group $425.39 -28.72 (-6.32%) 52-Week Range $424.81 ▼ $630.73 Dividend Yield 1.97% P/E Ratio 27.44 Get UnitedHealth Group alerts: Price Target $610.24 The company's stock had been recovering off its double-bottom support levels around $435, rebounding as high as $606.36 on Apr. 11, 2025, ahead of its first quarter 2025 earnings report. Add to Watchlist Indeed, it rose from a pariah back to pole position as health insurance stocks were seen as recession-resistant saf ...

I have not written to you about UnitedHealth Group Incorporated (NYSE: UNH ) before, though over time I have owned a modest on-and-off position in the stock.Individual investor focused upon a limited number of diversified stocks. Seeks stocks selling below fair value estimates; favors dividend growth and/or income. Advocates fundamental investment analysis, supplemented by the technical charts. Options strategies primarily employed to generate additional income or hedge risk. If interested, you may find out ...

UnitedHealth Group (UNH) , the largest U.S. health insurer, reported dismal first-quarter 2025 results. It missed both earnings and revenue estimates and lowered its full-year guidance amid rising medical costs. This sent UNH's shares into the biggest tailspin in more than two decades, spreading pessimism in the overall insurance sector. UNH shares tumbled 22.4% on the day following the results, marking the worst daily decline since 1998 and the company’s fourth-worst day on Wall Street since going public i ...